Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • cement_head
    Senior Member
    • Mar 2012
    • 264

    AlienTrimmer Question

    Hello,

    When using AlienTrimmer to trim PE data, it generates three files: R1 trimmed, R2 trimmed, and a "singles" file (one read failed the QC test). When you do a de novo assembly, does one use all three files? Or just the R1 / R2 PE files?

    Thanks,
    Andor
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Some assemblers can take both paired and unpaired reads at the same time, but if you have sufficient coverage with the paired reads only, I'd recommend throwing away the singletons. They add complexity and are likely to be lower quality anyway; for example, they may be reads that should have been removed (due to the presence of adapters or other non-genomic artifacts) but were not removed because they had so many errors it prevented detection.

    Comment

    • cement_head
      Senior Member
      • Mar 2012
      • 264

      #3
      Originally posted by Brian Bushnell View Post
      Some assemblers can take both paired and unpaired reads at the same time, but if you have sufficient coverage with the paired reads only, I'd recommend throwing away the singletons. They add complexity and are likely to be lower quality anyway; for example, they may be reads that should have been removed (due to the presence of adapters or other non-genomic artifacts) but were not removed because they had so many errors it prevented detection.
      Cheers - thanks - that was exactly the direction I was leaning.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 12:17 PM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 11:41 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...